Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA in High Risk Localized Prostate Cancer

NCT07222436 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT07222436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Recruiting
Start date
September 23, 2025
Completion date
September 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer